Swiss pharmaceutical giant Roche has said it will buy maker of lung disease therapies InterMune for $8.3bn (£5bn). Intermune, which is based in Brisbane, California, makes a medicine for idiopathic pulmonary fibrosis, a deadly disease which scars the lungs. via Pocket http://ift.tt/1zoeEA7
No comments:
Post a Comment